Online Therapy: 2026 AI Market Discovery Index

Answer Capsule

In the online therapy category for June 2026, AI systems are concentrating buyer attention on a narrow set of platforms. Talkspace leads with the highest recommendation coverage and strongest shortlist presence across all buyer stages. BetterHelp holds second position with strong rank-one performance but trails in recommendation volume. Grow Therapy and Brightside Health are emerging challengers with high sentiment but lower overall recommendation power. Several brands, including Amwell, Cerebral, and Calmerry, appear in AI responses but rarely earn ranked recommendations, creating a significant gap between visibility and commercial influence.

Executive Summary

The online therapy category is experiencing a clear AI-driven shortlist compression. Across 1,252 observations spanning consideration, evaluation, and decision-stage prompts, two platforms dominate AI recommendations while a second tier of challengers competes for the remaining shortlist positions. Talkspace captures 10.6% of the total modeled AI opportunity value of $21.9 million per month, with BetterHelp close behind at 9.5%. Together, these two platforms account for more than 20% of all AI recommendation value in the category.

The critical finding is that recommendation power does not follow brand awareness. Several platforms with significant consumer recognition appear in AI responses at moderate rates but fail to convert that presence into ranked recommendations. Amwell appears in 12.2% of all observations but earns a valid recommendation in only 4.7% of cases. Cerebral shows a similar pattern, with 11.6% presence but only 4.0% recommendation coverage. This gap between being mentioned and being recommended represents a structural disadvantage in AI-driven buyer discovery.

Grow Therapy and Brightside Health represent the most interesting challenger dynamic. Both platforms achieve high net sentiment scores (0.68 and 0.79 respectively) and meaningful recommendation coverage, but they trail the leaders significantly in top-three and rank-one rates. Brightside Health in particular posts the highest net sentiment score in the category at 0.79, yet its average recommended rank of 3.5 suggests it is frequently listed but not prioritized.

The commercial implication is direct. AI systems are acting as de facto shortlist builders for online therapy buyers. Platforms that earn consistent ranked recommendations across multiple buyer stages capture disproportionate value. Platforms that are merely present in AI responses without recommendation credit are effectively invisible to the buyer journey.

The AI Discovery Shift in Online Therapy

Traditional search visibility in online therapy has long been driven by paid advertising, affiliate content, and brand recognition. AI search systems are rewriting that model. When a consumer asks an AI assistant for the best online therapy platform or compares pricing between services, the AI does not return a list of paid placements. It returns a synthesized answer built from available public sources, and the platforms it selects for shortlists are the ones that earn buyer attention.

This shift matters because AI platforms are becoming the first stop for therapy seekers. The three public clusters in this benchmark represent the most common buyer intents: discovery of platforms, direct comparisons between services, and pricing evaluation. In each of these moments, the AI acts as a shortlist curator. Being mentioned is not enough. Being recommended in a ranked position is what drives actual buyer consideration.

The distribution of recommendation power confirms how concentrated this market has become. Talkspace appears in 70.5% of all observations and earns a valid recommendation in 33.3% of cases. BetterHelp appears in 59.5% of observations with 22.8% recommendation coverage. Every other platform in the category falls below 20% recommendation coverage, with most below 10%. This creates a two-tier market where the leaders capture the majority of AI-driven buyer attention while the rest compete for residual shortlist positions.

Directional Category Leaders

1. Talkspace

Talkspace is the clear leader in AI recommendation power across the online therapy category. It appears in 70.5% of all observations and earns a valid recommendation in 33.3% of cases, the highest recommendation coverage in the category. Its top-three rate of 30.3% and rank-one rate of 13.0% demonstrate consistent shortlist dominance. With an average recommended rank of 1.9, Talkspace typically appears in the first or second position when recommended. Its modeled monthly AI authority value of $2.32 million represents 10.6% of the total category opportunity.

The public interpretation: Talkspace has built the strongest AI recommendation architecture in online therapy, appearing as the top or near-top choice across discovery, comparison, and pricing prompts.

2. BetterHelp

BetterHelp holds second position with exceptional rank-one performance. It appears in 59.5% of observations with 22.8% recommendation coverage. Its rank-one rate of 14.8% is the highest in the category, and its average recommended rank of 1.47 is the strongest among all platforms. BetterHelp's recommendation coverage trails Talkspace by a meaningful margin, and its net sentiment score of 0.42 is lower than several challengers. Its modeled monthly AI authority value of $2.09 million represents 9.5% of the category opportunity.

The public interpretation: BetterHelp wins the top position more often than any competitor when recommended, but it is recommended less frequently than Talkspace across the full range of buyer prompts.

3. Grow Therapy

Grow Therapy has established itself as the strongest challenger in the category. It appears in 31.9% of observations with 18.9% recommendation coverage and a net sentiment score of 0.68, the second highest in the category. Its top-three rate of 16.2% and rank-one rate of 5.5% place it well ahead of the remaining field. Its modeled monthly AI authority value of $498,636 represents 2.3% of the category opportunity.

The public interpretation: Grow Therapy is the most positively framed challenger brand, with recommendation coverage and sentiment that position it as a credible alternative to the two market leaders.

4. Brightside Health

Brightside Health carries the highest net sentiment score in the category at 0.79, meaning AI responses frame the platform overwhelmingly positively. It appears in 22.8% of observations with 16.4% recommendation coverage. However, its average recommended rank of 3.5 and top-three rate of 7.2% indicate it is frequently listed but not prioritized at the top of shortlists. Its modeled monthly AI authority value of $356,867 represents 1.6% of the category opportunity.

The public interpretation: Brightside Health is trusted and positively discussed by AI systems, but it is not yet earning the top shortlist positions that convert browser intent into buyer action.

5. Online-Therapy.com

Online-Therapy.com appears in 23.3% of observations with 12.2% recommendation coverage and a net sentiment score of 0.58. Its top-three rate of 4.0% and average recommended rank of 3.69 place it in the middle of AI-generated shortlists when it appears. Its modeled monthly AI authority value of $134,437 represents 0.6% of the category opportunity.

The public interpretation: Online-Therapy.com holds moderate AI visibility with positive framing but lacks the recommendation frequency and rank position to challenge the leading tier.

The Buying Moments That Now Decide the Category

Best Online Therapy Platforms

This cluster represents the discovery stage where buyers first identify available platforms. It generated 416 observations with a modeled monthly opportunity value of $7.13 million. Talkspace leads with a 29.3% top-three rate and 15.6% rank-one rate. BetterHelp follows with 20.2% top-three and 14.9% rank-one. Grow Therapy shows strong performance here at 17.1% top-three and 7.2% rank-one. This is the most competitive cluster and the most commercially important for first-impression capture, since buyers who form a shortlist at the discovery stage rarely expand it significantly afterward.

Online Therapy Platform Comparisons

This cluster captures buyers actively comparing platforms against each other, the moment when brand differentiation either holds or collapses. It generated 475 observations with a modeled monthly opportunity value of $9.89 million. Talkspace leads with 29.3% top-three and 12.6% rank-one. BetterHelp holds 20.4% top-three and 13.5% rank-one. Grow Therapy's top-three rate drops to 13.7% in this cluster compared to its discovery-stage performance, suggesting its comparative positioning is less well-supported by available public sources. A 1.25x buyer stage multiplier increases the commercial weight of this cluster.

Online Therapy Pricing and Cost

This is the highest-intent cluster, representing buyers ready to choose based on cost. It generated 361 observations with a modeled monthly opportunity value of $4.84 million. A 1.5x buyer stage multiplier makes this the most valuable cluster per observation. BetterHelp leads here with 23.8% top-three and 16.3% rank-one. Talkspace follows with 32.7% top-three but only 10.5% rank-one. Grow Therapy and Brightside Health both show 22.7% recommendation coverage in this cluster, suggesting they compete more effectively on pricing conversations than on broader discovery prompts.

Why Recommendation Power Is Concentrating

Recommendation power in online therapy is concentrating around platforms with strong, consistent public evidence layers. Talkspace and BetterHelp benefit from extensive review content, comparison articles, clinical references, and brand authority signals that AI systems can retrieve and trust. The data shows that platforms with higher recommendation coverage also tend to have higher positive visibility rates, indicating that AI systems are drawing from richer and more consistently positive public sources when forming their shortlists.

Citation architecture is the underlying mechanism. Platforms that appear in authoritative comparison guides, clinical directories, and verified review sources are more likely to be recommended than those that depend primarily on brand advertising or direct traffic. Brightside Health's net sentiment score of 0.79, despite lower recommendation frequency, suggests that when it is discussed in public sources, the framing is strongly positive. The challenge is that those positive sources are not yet numerous or broadly distributed enough to drive frequent recommendations across all buyer-stage prompts.

The gap between presence and recommendation is the most commercially meaningful metric in this dataset. AI systems are not simply surfacing every platform they are aware of. They are making active shortlist decisions, and the platforms that understand how to build the public evidence layers that support those decisions will continue to widen their advantage.

The Category's Most Visible Warning Sign

The most striking pattern in this benchmark is the performance of Amwell. Despite being a well-funded and established telehealth platform with significant brand recognition, Amwell appears in 12.2% of AI observations but earns a valid recommendation in only 4.7% of cases. Its top-three rate is 1.9%, and its average recommended rank of 4.0 places it near the bottom of most AI-generated shortlists. Its modeled monthly AI authority value of $89,455 represents 0.4% of the category opportunity.

This is not a visibility problem. Amwell is present in AI responses. It is a recommendation problem. AI systems are aware of Amwell but are not selecting it for shortlists. For a platform with Amwell's market position and resources, this gap between awareness and recommendation represents a structural disadvantage that will compound as more buyers begin their therapy search through AI platforms. Presence without recommendation credit does not drive buyer consideration, and in a market compressing toward two dominant players, the cost of that gap is rising.

What This Means for the Category

The online therapy market is experiencing shortlist compression at a pace that reflects how quickly AI systems are becoming the primary discovery channel for health-adjacent consumer decisions. Two platforms capture the majority of recommendation value, and the remaining eight compete for a shrinking share of AI-driven buyer attention. This pattern is likely to intensify as AI assistants become more embedded in how consumers research mental health options.

Competitor displacement is already visible in the data. The gap between Talkspace and BetterHelp at the top and the rest of the field is not marginal. It is a significant difference in recommendation coverage, rank position, and modeled value. Platforms that cannot close that gap through stronger evidence architecture will find themselves increasingly confined to factual references rather than active shortlist positions.

Trust-source dependency is becoming the defining competitive variable. Platforms that invest in the public evidence layers that AI systems draw from, including clinical references, verified reviews, authoritative comparison content, and consistent citation presence, will earn higher recommendation rates. Platforms that rely on advertising spend or direct brand traffic will find those channels increasingly decoupled from the AI-driven buyer journey.

AI discovery is not a supplemental channel in online therapy. It is becoming the primary moment where buyer shortlists are formed. Platforms that are not performing well in these AI-driven decision moments will need stronger entity architecture, richer public source layers, and more intentional citation strategies to remain commercially competitive as the market continues to shift.

What This Public Benchmark Does Not Include

- Full cluster dataset covering all 10 buyer intent clusters

- Prompt-level response tables showing exact AI outputs by platform

- Citation-source failure maps identifying which sources are missing or underperforming

- Platform-by-platform recovery priorities for each of the six AI systems

- Entity and schema diagnostics for structured data gaps

- Source-layer gap analysis across review, clinical, and comparison content

- Company-specific content recommendations for improving recommendation eligibility

- Exact competitor threat profiles for each brand in the study

- Full paid opportunity model with platform-level valuation breakdowns

This page shows the market shape. The paid report shows the repair map.

Methodology and Disclaimers

Market studied: Online therapy platforms, including direct-to-consumer therapy services, telehealth counseling platforms, and mental health support services.

Brands and entities included: BetterHelp, Talkspace, Grow Therapy, Brightside Health, Online-Therapy.com, 7 Cups, Amwell, Cerebral, Regain, and Calmerry. This universe covers the major publicly visible online therapy platforms but is not a full market census.

Data collection window: June 2026, based on a snapshot of AI platform outputs during the reporting month.

AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.

Observations analyzed: 1,252 observations across all platforms and clusters.

Prompt categories: Three public high-intent clusters were analyzed: Best Online Therapy Platforms (consideration stage), Online Therapy Platform Comparisons (evaluation stage), and Online Therapy Pricing and Cost (decision stage). The full report includes 10 clusters.

Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment or rank position.

Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality appearance that earns recommendation credit. Visibility is not the same as recommendation credit. This distinction is the basis for separating presence metrics from recommendation metrics throughout the report.

Ranking and scoring metrics used: Valid recommendation coverage, top-three rate, rank-one rate, top-ten rate, average recommended rank, net sentiment score, positive visibility rate, neutral visibility rate, negative visibility rate, monthly AI authority value, monthly AI recommendation value, monthly AI visibility assist value, and captured share of AI opportunity.

Limitations: This is a point-in-time benchmark. AI outputs change with model updates, source changes, and prompt variations. Modeled values are estimates based on commercial intent signals and are not revenue figures. Platform weights are equal across all six tested AI systems. This report is not a full audit or full market census.

For a Company-Specific Authority Index Report

The deeper analysis would show which prompts each company wins or loses, which AI platforms are under-recognizing the brand, which source layers are shaping recommendations, and what changes may improve AI shortlist eligibility.